ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,103.60
      0.18%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.66
      0.08%
      Bitcoin
      67,140.11
      1.48%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Acceleron Pharma Inc (XLRN)

      7. Acceleron Pharma Inc (XLRN) News

      XLRN

      Acceleron Pharma (XLRN)

      Acceleron Pharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:XLRN
      DateTimeSourceHeadlineSymbolCompany
      12/02/20219:01AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:XLRNAcceleron Pharma Inc
      11/24/20213:48PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XLRNAcceleron Pharma Inc
      11/23/20215:21AMTipRanksMerck Completes Acquisition of Acceleron PharmaNASDAQ:XLRNAcceleron Pharma Inc
      11/22/20219:13AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
      11/22/20219:12AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
      11/22/20219:11AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
      11/22/20219:10AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
      11/22/20219:09AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
      11/22/20219:08AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
      11/22/20219:08AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
      11/22/20219:07AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
      11/22/20219:05AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
      11/22/20219:04AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
      11/22/20219:03AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
      11/22/20218:52AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XLRNAcceleron Pharma Inc
      11/22/20217:02AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:XLRNAcceleron Pharma Inc
      11/17/20212:26PMBusiness WireAvoro Capital Urges Acceleron Shareholders Not to Tender Into Merck’s Inadequate OfferNASDAQ:XLRNAcceleron Pharma Inc
      11/17/20217:26AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:XLRNAcceleron Pharma Inc
      11/17/20217:01AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:XLRNAcceleron Pharma Inc
      11/12/20214:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
      11/12/20217:01AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:XLRNAcceleron Pharma Inc
      11/10/202111:37AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:XLRNAcceleron Pharma Inc
      11/09/20215:31PMBusiness WireAvoro Capital Releases Presentation Detailing Why Acceleron Shareholders Should Not Tender Into Merck’s Inadequate OfferNASDAQ:XLRNAcceleron Pharma Inc
      11/08/20215:17PMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:XLRNAcceleron Pharma Inc
      11/08/20215:15PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:XLRNAcceleron Pharma Inc
      11/04/20214:14PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XLRNAcceleron Pharma Inc
      11/04/20214:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XLRNAcceleron Pharma Inc
      11/04/20214:01PMBusiness WireAcceleron Reports Third Quarter 2021 Financial ResultsNASDAQ:XLRNAcceleron Pharma Inc
      10/28/20218:00AMBusiness WireAvoro Capital Issues Open Letter to Fellow Acceleron Pharma ShareholdersNASDAQ:XLRNAcceleron Pharma Inc
      10/27/20217:10AMBusiness WireAcceleron Announces Third Quarter 2021 REBLOZYL® Net SalesNASDAQ:XLRNAcceleron Pharma Inc
       Showing the most relevant articles for your search:NASDAQ:XLRN